Cargando…
Studies of the symmetric binding mode of daclatasvir and analogs using a new homology model of HCV NS5A GT-4a
CONTEXT: Egypt has a high prevalence of the hepatitis C virus (HCV) genotype 4a (GT-4a). Unfortunately, the high resistance it exhibited still was not given the deserved attention in the scientific community. There is currently no consensus on the NS5A binding site because the crystal structure of H...
Autores principales: | Saad, Kholoud A., Eldawy, Mohammed A., Elokely, Khaled M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800351/ https://www.ncbi.nlm.nih.gov/pubmed/36580076 http://dx.doi.org/10.1007/s00894-022-05420-4 |
Ejemplares similares
-
Asymmetric Binding to NS5A
by Daclatasvir (BMS-790052)
and Analogs Suggests Two Novel Modes of HCV Inhibition
por: Nettles, James H., et al.
Publicado: (2014) -
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors
por: Nasr, Tamer, et al.
Publicado: (2022) -
Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection
por: Kumada, Hiromitsu, et al.
Publicado: (2014) -
Fluorescence Spectrometric Determination of Drugs Containing α-Methylene Sulfone/Sulfonamide Functional Groups Using N
(1)-Methylnicotinamide Chloride as a Fluorogenic Agent
por: Elokely, Khaled M., et al.
Publicado: (2011) -
The Discovery and Development of Daclatasvir: An Inhibitor of the Hepatitis C Virus NS5A Replication Complex
por: Meanwell, Nicholas A., et al.
Publicado: (2018)